Research Firm CEO Who Interacted with FDA on Company’s Behalf Also Charged The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and...
The “Pharma and ESG – The Patient Perspective – The Views of 1,500 Patient Groups” report has been added to ResearchAndMarkets.com’s offering. This analysis of patient-group opinions on ESG is based on two online...
Simulations Plus, Inc., a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced that the U.S. Food and Drug Administration (FDA) has renewed its...
Backers say the amendment will let people produce food without government interference, but critics see problems for food safety, animal welfare and the environment. (Washington Post) – Maine voters approved...